太火鸟 设计交易 设计案例 设计公司 社区 项目管理 增值服务 THN-X 关于太火鸟 联系我们

Hypodermic needle for insulin injection [NANOPASS33]


1/1

This is an insulin syringe for use by patients with diabetes. It boasts the world's smallest needle size (33G; 0.2mm). It is 20% thinner than conventional 31G needles. This innovative technology satisfies competing needs for a smaller, painless needle on the one hand, and a certain amount of thickness to allow for smooth delivery of the medicine on the other. This is the world's first syringe with "Double taper construction", featuring a very fine tip that gradually tapers into a wider diameter. Conventional syringes are shaped like pipes in which both the inside and the outside diameters are fixed. As the diameter of these needles is reduced, the resistance to the liquid being injected increases, making injections more difficult at small diameters. In order to overcome this limitation and achieve even smaller needle sizes, the "Hans Poisille Principle" was applied, and it was discovered that if a tapered configuration was used, the resistance could be controlled even at very fine tip diameters.

发布 2020-11-25 来源 https://www.g-mark.org
最新评论

设计师

Tomonori Ijiri, Jun Tsubota, Seinor Staff, Design Section, Marketing Department, TERUMO CORPORATION

设计奖项

颜色

对该产品有疑问?点击反馈

相关推荐

  • 意见反馈

    公众号
    看案例
    电话